HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


COVID-19 Claims for OTC Intravenous Drips Found In Advertising On Both Sides Of Atlantic

Executive Summary

UK agency advises two medical spas to discontinue claims suggesting IV drips prevent or cure COVID-19. In separate rulings to the companies, ASA notes the UK MHRA says including COVID-19 in promotions would bring the IV drips under medicines regulation.

You may also be interested in...

US Hospitals’ COVID-19 Treatment Protocols Aren’t Prescriptions To Make Vitamin C Ad Claims

Marketer of Billy’s Infinity-C supplement line discontinues social media post that COVID-19 patients in hospitals are receiving high doses of vitamin C. BBB National Programs division says the post implies consumers can prevent contracting the virus through vitamin C use. 

COVID-19 Mentions Prohibited From Supplement Ads - UK Regulator

Dietary supplement ads should not make any explicit or implicit references to COVID-19, with immunity boosting claims also strictly off limits, says UK regulator the Advertising Standards Authority.

Like Health And Economic Impact, COVID-19 Unprecedented As Unlawful Claims Driver

Variety of products advertised with false coronavirus claims also grew in FTC's latest warnings submitted. It warned 21 firms on claims for products including IV drips, ozone therapy and stem cell treatments.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts